The microtubule targeting agents eribulin and paclitaxel activate similar signaling pathways and induce cell death predominantly in a caspase-independent manner

Identification of JNK1 as a predicting biomarker for ABT-199 and paclitaxel combination treatment

(2018) Ting Song et al.   BIOCHEMICAL PHARMACOLOGY

The DEAD-box RNA helicase DDX41 is a novel repressor of p21WAF1/CIP1mRNA translation

(2017) Dominik Peters et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Eribulin: an effective therapeutic option in liposarcoma

(2017) Manjulika Das   LANCET ONCOLOGY

Microtubule destabilising agents: far more than just antimitotic anticancer drugs

(2016) Darcy Bates et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics

(2016) Rosie Elizabeth Ann Gutteridge et al.   MOLECULAR CANCER THERAPEUTICS

Eribulin synergizes with Polo-like kinase 1 inhibitors to induce apoptosis in rhabdomyosarcoma

(2015) Angelika Stehle et al.   CANCER LETTERS

Eribulin Mesylate: Mechanism of Action of a Unique Microtubule-Targeting Agent

(2015) N. F. Dybdal-Hargreaves et al.   CLINICAL CANCER RESEARCH

Bcl-2—Enhanced Efficacy of Microtubule-Targeting Chemotherapy through Bim Overexpression: Implications for Cancer Treatment

(2015) Amandine Savry et al.   NEOPLASIA

Cytotoxicity of Paclitaxel in Breast Cancer Is due to Chromosome Missegregation on Multipolar Spindles

(2014) L. M. Zasadil et al.   Science Translational Medicine

Caspase-2 is involved in cell death induction by taxanes in breast cancer cells

(2013) Michael Jelínek et al.   Cancer Cell International

Mitosis and apoptosis: how is the balance set?

(2013) Caroline H Topham et al.   CURRENT OPINION IN CELL BIOLOGY

The MPS1 Family of Protein Kinases

(2012) Xuedong Liu et al.   Annual Review of Biochemistry

Microtubule attachment and spindle assembly checkpoint signalling at the kinetochore

(2012) Emily A. Foley et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Eribulin Mesylate

(2011) S. Jain et al.   CLINICAL CANCER RESEARCH

Eribulin—A review of preclinical and clinical studies

(2011) Umang Swami et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Eribulin mesylate

(2011) Timothy K. Huyck et al.   NATURE REVIEWS DRUG DISCOVERY

Mitotic catastrophe: a mechanism for avoiding genomic instability

(2011) Ilio Vitale et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Eribulin Induces Irreversible Mitotic Blockade: Implications of Cell-Based Pharmacodynamics forIn vivoEfficacy under Intermittent Dosing Conditions

(2010) Murray J. Towle et al.   CANCER RESEARCH

A chemical tool box defines mitotic and interphase roles for Mps1 kinase

(2010) Weijie Lan et al.   JOURNAL OF CELL BIOLOGY

Microtubule-binding agents: a dynamic field of cancer therapeutics

(2010) Charles Dumontet et al.   NATURE REVIEWS DRUG DISCOVERY

Taxol induces paraptosis independent of both protein synthesis and MAPK pathway

(2009) Qingrui Sun et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Cancer Cells Display Profound Intra- and Interline Variation following Prolonged Exposure to Antimitotic Drugs

(2008) Karen E. Gascoigne et al.   CANCER CELL

Regulation of Bcl-2 Family Proteins by Posttranslational Modifications

(2008) Anthony Letai et al.   CURRENT MOLECULAR MEDICINE

Caspase-2 is required for cell death induced by cytoskeletal disruption

(2008) L H Ho et al.   ONCOGENE

Taxanes, microtubules and chemoresistant breast cancer

(2007) Barbara T. McGrogan et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Taxol-induced mitochondrial stress in melanoma cells is mediated by activation of c-Jun N-terminal kinase (JNK) and p38 pathways via uncoupling protein 2

(2007) Denis Selimovic et al.   CELLULAR SIGNALLING